Alternative regulation principles for the production of recombinant proteins in Escherichia coli

被引:20
作者
Sawers, G
Jarsch, M
机构
[1] BOEHRINGER MANNHEIM GMBH,WERK PENZBERG,DIV THERAPEUT,F&E BIOTECHNOL,D-82372 PENZBERG,GERMANY
[2] JOHN INNES CTR PLANT SCI RES,NITROGEN FIXAT LAB,NORWICH NR4 7UH,NORFOLK,ENGLAND
关键词
D O I
10.1007/s002530050775
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Established expression vectors exploiting regulated promoters such as the lac or the promoters have economic and technical limitations when used for the industrial production of recombinant proteins. Consequently, alternative expression systems are being developed that can be more readily manipulated while maintaining high yields of protein. Several suitable expression vectors have been described for use in Escherichia coli that are based on promoters the activity of which is under metabolic control. This article discusses the advantages and disadvantages of a cross-section of these expression systems, how they compare with established systems and how they can be applied to the industrial-scale production of recombinant proteins.
引用
收藏
页码:1 / 9
页数:9
相关论文
共 54 条
[1]  
BALBAS P, 1990, METHOD ENZYMOL, V185, P14
[2]  
Beckwith J, 1987, ESCHERICHIA COLI SAL, P1444
[3]   THE MGLB SEQUENCE OF SALMONELLA-TYPHIMURIUM LT2 - PROMOTER ANALYSIS BY GENE FUSIONS AND EVIDENCE FOR A DIVERGENTLY ORIENTED GENE CODING FOR THE MGL REPRESSOR [J].
BENNERLUGER, D ;
BOOS, W .
MOLECULAR & GENERAL GENETICS, 1988, 214 (03) :579-587
[4]  
BOCK A, 1990, Patent No. 393684
[5]  
BROSIUS J, 1985, J BIOL CHEM, V260, P3539
[6]   A NEW FAMILY OF SUGAR-INDUCIBLE EXPRESSION VECTORS FOR ESCHERICHIA-COLI [J].
CAGNON, C ;
VALVERDE, V ;
MASSON, JM .
PROTEIN ENGINEERING, 1991, 4 (07) :843-847
[7]   HIGH-LEVEL ESCHERICHIA-COLI EXPRESSION AND PRODUCTION OF A BIVALENT HUMANIZED ANTIBODY FRAGMENT [J].
CARTER, P ;
KELLEY, RF ;
RODRIGUES, ML ;
SNEDECOR, B ;
COVARRUBIAS, M ;
VELLIGAN, MD ;
WONG, WLT ;
ROWLAND, AM ;
KOTTS, CE ;
CARVER, ME ;
YANG, M ;
BOURELL, JH ;
SHEPARD, HM ;
HENNER, D .
BIO-TECHNOLOGY, 1992, 10 (02) :163-167
[8]  
CHARLES IG, 1992, Patent No. 9215688
[9]   USE OF THE NIRB PROMOTER TO DIRECT THE STABLE EXPRESSION OF HETEROLOGOUS ANTIGENS IN SALMONELLA ORAL VACCINE STRAINS - DEVELOPMENT OF A SINGLE-DOSE ORAL TETANUS VACCINE [J].
CHATFIELD, SN ;
CHARLES, IG ;
MAKOFF, AJ ;
OXER, MD ;
DOUGAN, G ;
PICKARD, D ;
SLATER, D ;
FAIRWEATHER, NF .
BIO-TECHNOLOGY, 1992, 10 (08) :888-892
[10]   CONSTRUCTION AND CHARACTERIZATION OF A NOVEL CROSS-REGULATION SYSTEM FOR REGULATING CLONED GENE-EXPRESSION IN ESCHERICHIA-COLI [J].
CHEN, W ;
KALLIO, PT ;
BAILEY, JE .
GENE, 1993, 130 (01) :15-22